Admin

Admin

The Next Biotech Competition May Be Won Before a Drug Reaches the Lab

Advanced DNA synthesis equipment inside a biotechnology research laboratory

Biotechnology competition is shifting upstream, toward the technologies that turn biological designs into physical experiments. Azenta’s October 2026 licensing agreement with Elegen and acquisition of SynPlexity demonstrate how established life sciences companies are investing in gene synthesis and high-throughput biological…